Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Targum

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Human Psychopharmacology|July 25, 2012
A global measure to assess switching antipsychotic medications in the treatment of schizophreniaSteven D Targum, Linda Pestreich, Petra Reksoprodjo, et al.
Frontiers in Psychiatry|June 19, 2023
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressantsChristian Yavorsky, Elizabeth Ballard, Mark Opler, et al.
Journal of Psychiatric Research|January 9, 2026
A novel, experimental design to assess rapid antidepressant action: Results from a phase 1b randomized trial of NV-5138Steven D Targum, Gerard Sanacora, Andrea E Formella, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2014
Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patientsSteven D Targum, Daniel J Burch, Mahnaz Asgharnejad, et al.
Schizophrenia Research|August 27, 2024
Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptomsSteven D Targum, Tingting Ge, Mahnaz Asgharnejad, et al.
Journal of Clinical Psychopharmacology|March 6, 2012
Application of external review for subject selection in a schizophrenia trialSteven D Targum, Jessica A Little, Enrique Lopez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2015
Impact of BPRS interview length on ratings reliability in a schizophrenia trialSteven D Targum, J Cara Pendergrass, Chelsea Toner, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
CNS Neuroscience & Therapeutics|September 23, 2009
RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)Gregory M Chandler, Dan V Iosifescu, Mark H Pollack, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 25, 2016
Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled studySteven D Targum, Trisha Suppes, J Cara Pendergrass, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Human Psychopharmacology|July 25, 2012
A global measure to assess switching antipsychotic medications in the treatment of schizophreniaSteven D Targum, Linda Pestreich, Petra Reksoprodjo, et al.
Frontiers in Psychiatry|June 19, 2023
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressantsChristian Yavorsky, Elizabeth Ballard, Mark Opler, et al.
Journal of Psychiatric Research|January 9, 2026
A novel, experimental design to assess rapid antidepressant action: Results from a phase 1b randomized trial of NV-5138Steven D Targum, Gerard Sanacora, Andrea E Formella, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2014
Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patientsSteven D Targum, Daniel J Burch, Mahnaz Asgharnejad, et al.
Schizophrenia Research|August 27, 2024
Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptomsSteven D Targum, Tingting Ge, Mahnaz Asgharnejad, et al.
Journal of Clinical Psychopharmacology|March 6, 2012
Application of external review for subject selection in a schizophrenia trialSteven D Targum, Jessica A Little, Enrique Lopez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2015
Impact of BPRS interview length on ratings reliability in a schizophrenia trialSteven D Targum, J Cara Pendergrass, Chelsea Toner, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
CNS Neuroscience & Therapeutics|September 23, 2009
RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)Gregory M Chandler, Dan V Iosifescu, Mark H Pollack, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 25, 2016
Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled studySteven D Targum, Trisha Suppes, J Cara Pendergrass, et al.
Pageof 8